Navigation Links
Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study

* Glivec found to dramatically reduce the risk of cancer returning after surgery for Kit-positive gastrointestinal stromal tumors (GIST)

* Patients receiving placebo in this trial will now be offered Glivec

* Global regulatory submissions planned for use of Glivec as adjuvant therapy in GIST patients following surgery to remove primary tumor

* Glivec already approved as effective therapy for patients with advanced metastatic or inoperable Kit-positive GIST

BASEL, Switzerland, April 12, 2007 - Investigators will begin offering Glivec® (imatinib)[*] to patients receiving placebo in a major North American clinical trial after after an interim analysis showed participants with Kit-positive gastrointestinal stromal tumors treated with Glivec following surgery were significantly less likely to experience a return of their cancer compared to those not taking this innovative therapy.

The interim analysis showed no recurrence of cancer in approximately 97% of patients given Glivec for a year after surgery to remove tumors, compared to approximately 83% of those who underwent surgery but received a placebo. The investigators made these results public because the study had met its primary endpoint in terms of the rate of recurrence-free survival.

The study involving more than 600 patients was sponsored by the National Cancer Institute (NCI), which is part of the US National Institutes of Health (NIH). It was conducted at multiple cancer centers in the US and Canada, and was led by the American College of Surgeons Oncology Group. Novartis supplied Glivec for use in the study, and also provided partial funding under a Cooperative Research and Development Agreement with NCI to support the clinical development of Glivec.

Glivec has already been confirmed as an effective therapy in its approved use for patients with advanced metastatic or unresectable (inoperable) Kit-positi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... critical to pharmaceutical brand recognition and success. ... LLC conducted a study to provide pharmaceutical and ... of investment (FTEs and budget) that are being ... Pharmaceutical and biotech marketing managers can utilize this ...
(Date:5/22/2015)... , May 22, 2015 The Assistance Fund ... This program provides financial assistance for copay to individuals ... to announce the addition of the Melanoma Copay Assistance ... Mark McGreevy , executive director. "With each additional program ... of a world where no one is denied access ...
(Date:5/22/2015)... YORK , May 22, 2015 ... of the $13 billion global cardiac rhythm management ... Information.  Kalorama found that Medtronic, St. Jude Medical, ... command 80% of this market segment. The healthcare ... Device Markets , uses 2015 as a base ...
Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4
... (Nasdaq: AMLN ) will be presenting at the ... 2011 at 4:10 p.m. ET / 1:10 p.m. PT . ... officer at Amylin Pharmaceuticals, will provide a corporate overview. ... section of Amylin,s corporate website at www.amylin.com , and ...
... Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that ... Investor Conference on Tuesday, February 15, 2011 at 3:00 p.m. ... the Waldorf-Astoria Hotel in New York City.  Steve Worland, Ph.D., ... overview of Anadys and its clinical development programs. ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference 2
(Date:5/25/2015)... BC (PRWEB) May 25, 2015 According ... http://www.idataresearch.com ), market growth in hip external fixation market ... the aging U.S. population and advancements in infection prevention ... increases. These fractures are currently accounting for the largest ... commonly associated with falls and accidents. As a result, ...
(Date:5/25/2015)... San Rafael, CA (PRWEB) May 25, 2015 ... Field for a free two-hour instructional clinic. Irish National ... with campers and give them a taste of her coaching ... San Anselmo and Novato. Camps in Novato are at Lynwood ... 3). , Novato High School - June 6th, 2015 ...
(Date:5/24/2015)... Pacific Prime has announced that they have launched the ... the cost of individual international health insurance. Titled: The Cost of ... cost of health insurance in six top expat destinations, which are ... Hong Kong , Singapore , China ... the UK , Article 2 presents an in-depth ...
(Date:5/24/2015)... Raleigh, NC (PRWEB) May 24, 2015 ... published a paper on air quality compliance issues that ... of American workers. Surviving Mesothelioma has just posted an ... it now. , The group found airborne asbestos ... inspection data collected between 1984 and 2011. , “Asbestos ...
(Date:5/24/2015)... May 24, 2015 Medicx Media ... Media strategy executive Jay Krihak as its head ... to ramp up its expertise and leadership position ... Pharmaceutical and Health sectors. , Krihak is an ... Most recently, Krihak led sales planning teams for ...
Breaking Medicine News(10 mins):Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2
... ... Products LLC is proud to announce the unveiling of its brand ... prices directly to the American Consumer. TouchstoneSaunas.com offers premium quality ... home. Constructed from the highest quality materials to provide many ...
... ... and Earth Day Celebration Saturday, April 17. , ... Golden, CO (PRWEB) April 17, 2010 -- Panorama Orthopedics & Spine ... and Arbor Day April 17. As part of its companywide green initiative, launched last year, ...
... As a ... team of expert negotiators who will act as buying agents for their elite group of ... New York, NY ... The Leading Physicians of the World is even further empowering their members by representing their ...
... A major ... debate surrounding the provision of open educational resources (OER) by revealing the key factors surrounding ... ... Dr Ann Hemingway investigated the barriers and enablers of free online public health education as ...
... ... Success , ... MA (Vocus) April 16, 2010 -- Blue Cross Blue Shield of Massachusetts ... over 160 firefighters in seven cities/towns (Arlington, Framingham, Hingham, Hudson, Ludlow, Peabody and Rockland) ...
... (April 15, 2010) -- Nine-year-old Morgan LaRue is the first ... that will magnetically lengthen her leg, sparing her the possibility ... The implant and extension took place at Texas Children,s Cancer ... Children,s Cancer Center or the device, please see http://bit.ly/MorganLaRue ...
Cached Medicine News:Health News:Touchstone Saunas Goes Online to Provide Premium Quality Infrared Saunas 2Health News:Panorama Orthopedics and the City of Westminster Join Forces to Improve the Environment through Tree Giveaway 2Health News:Exclusive Medical Organization, The Leading Physicians of the World Negotiates Equipment Contracts on Their Members Behalf 2Health News:BU Study Contributes to Online Health Education Debate 2Health News:BU Study Contributes to Online Health Education Debate 3Health News:Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge 2Health News:Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge 3Health News:Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge 4Health News:Texas Children's Cancer Center first in Texas to magnetically lengthen 9-year-old's leg as she grows 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This is a single-action instrument that features a spring handle....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: